• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Tome Biosciences Launches with $213M in Funding, Targets ‘New Era’ of Genomic Medicines

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 12, 2023 at 10:52: PM
via Biotech startup Tome Biosciences emerged from stealth on Tuesday armed with with $213 million in funding from prominent investors and technology licensed from from the Massachusetts Institute of Technology.

article source
 




Top Bottom
Back
Quote